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Vernonia amygdalina is commonly used for food and health purposes. Processing of the leaf for food is 
aimed at removing bitter tasting antinutritional principles like saponins. This study was designed to etermine 
the antipyretic and antinociceptive property of thecrude saponin from Vernonia amygdalina leaf. Standard 
procedure for antipyretic study using Saccharomyces cerevisiae induced pyrexia in rats; and acetic acid 
induced writhe, hot plate and cold tail flick tests for antinociceptive study in mice were used. Data for the crude 
saponin showed significant (P ≤ 0.05) dose dependent anal temperature decrease. The antinociceptive data in 
mice was significant (P ≤ 0.05) in the writhing test contrary to the cold tail flick test. In acute toxicity study, an 
LD50 of 5.1523 g/kg using oral route indicated it was practically non-toxic. Finding suggests that Vernonia 
amygdalina leaf prepared as diet could be of potential benefit to ailing persons with fever and/or pains, if 
processing technique adopts minimal loss of principles like saponins. 
© 2012 International Formulae Group. All rights reserved. 
 




Beyond their ready source as food, 
edible plants have over the years been 
demonstrated to possess medicinal value. 
Vegetables commonly eaten as food have 
been shown to be also beneficial in herbal 
therapy. The result of a study covering more 
than 220,000 people concluded that one and 
one half servings of green leafy vegetables per 
day, lowers the risk of Type II diabetes by 
14% (Patrice et al., 2010). 
Vernonia amygdalina, a local vegetable 
in Uganda, Nigeria and other African 
countries is widely used either as food or 
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herbal medicine (Izevbigie, 2005). Grown in a 
range of ecological zones in Africa and the 
Arabian Peninsula (Bonsi et al., 1995), the 
plant is commonly referred to as bitter leaf. 
Locally, it is called “omubirizi” or 
“omululuza” (West and Central Uganda); 
“olusia” (Luo, Kenya); or “ewuro”, “etidot” 
and “olugbo” (Southern Nigeria). In Southern 
Ethiopia, dairy farmers feed the boiled leaves 
to their stock during the dry period, and also 
to broilers as diet substitute (Bonsi et al., 
1995). 
Studies have indicated numerous 
phytochemicals to be present in the leaf 
extract of this plant (Izevbigie, 2005). The 
bitter taste of the leaf has been attributed to 
the presence of anti-nutritive principles like 
saponins, alkaloids, tannins and glycosides 
(Buttler and Bailey, 1973). Perhaps, the mode 
of preparing the leaves for human 
consumption which involves the socking and 
washing in warm water is aimed at reducing 
these bitter tasting. 
Saponins are glycosides widely 
distributed in plants. They are characterized 
by their structure which contains one or more 
sugar chains on a triterpene or steroid 
aglycone backbone also called sapogenin. The 
number of sugar chains in their structure 
determines if it is monodesmosidic (single 
sugar), bidesmosidic (double sugar) or 
tridesmosidic (trible sugar) saponin. The type 
of aglycone, respect to the nature and number 
of the functional group, as well as, the nature 
of the sugars, can vary in diverse groups of 
saponin compounds. While evidence has 
shown that the main non-food sources of 
saponins used in health and industrial 
applications include the soap bark tree, 
Medicago sativa, Aesculus hippocastanum, 
Glycyrrhiza glabra, the main dietary sources 
of saponins are the dicotyledon like legumes, 
(Güçlü-Ustündağ and Mazza, 2007). 
Saponins in foods have traditionally 
been considered bitter and unpleasant 
(Izevbigie, 2005). In some cases this has 
limited their use and therefore, most of the 
earlier research on processing has targeted 
their removal to facilitate human consumption 
(Ridout, 1991). Food and non-food sources of 
saponins have, however, come into renewed 
focus in recent years due to increasing 
evidence of their health benefits (Shi et al., 
2004). Recent research which showed 
saponins as active component in many herbal 
medicines also highlighted their contributions 
to the health benefit of foods (Liu and Henkel, 
2002). As such, the commercial potential of 
saponins has resulted in the development of 
new processing strategies (Muir et al., 2002). 
In line with this recent fact, saponin 
containing in herbs like V. amygdalina leaves 
prepared as food, may be of potential benefit 
to sick persons if a processing strategy that 
limits to a minimum, the loss of saponin is 
adopted. The objective of this study was 
therefore aimed at investigating the crude 
saponin from Vernonia amygdalina leaf 
aqueous extract for antinociceptive and 
antipyretic properties that may benefit ailing 
persons placed on the diet. 
 
MATERIALS AND METHODS 
Plant material and extraction 
The fresh leaves of Vernonia 
amygdalina were collected between June and 
July (raining season) in the South Western 
part of Uganda.  The leaf was identified by 
Julius Lejju (botanist) of the Biology 
Department, Faculty of Science, Mbarara 
University of Science and Technology. 
Specimen was retained with voucher number 
16-20 in the Department. The plant leaves 
were shade air-dried and grounded into a 
coarse powder. Using a similar method as 
employed by ethnics, the dried coarse powder 
was sieved to a 2000 g fine powder and 
macerated for three hours in warm (<80 oC) 
distilled water at a ratio of 131 g to 9 litres 
with intermittent shaking. The obtained 
extract was filtered while warm using a filter 
paper. The filtrate was further filtered using a 
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buckner filter assemblage (aided by a suction 
pump) and subsequently dried using an oven 
(at ≤ 80 oC) to obtain 360 g (18% yield) of 
residue. The obtained residue was stored in a 
desiccator for further use. 
 
Phytochemical screening 
Preliminary screening of the aqueous 
extract for the presence of phytochemicals 
was carried out using standard procedures 
(Harborne, 1973). 
 
Isolation of crude saponin 
The liquid-liquid extraction technique 
as described by Obadoni and Ochuko (2001) 
was adopted for the isolation. 20 g of the dried 
aqueous extract of V. amygdalina leaves 
dissolved in distilled water at a ratio of one to 
two was extracted thrice with diethyl ether 
(which was a half of the volume of the 
aqueous extract solution).  The diethyl ether 
layer was discarded and the retained aqueous 
layer extracted further with 60 ml n-butan-1-
ol (four times).  The n-butan-1-ol extracts 
were bulked together and washed four times 
using 10 ml of five percent NaCl. The washed 
extract was concentrated at < 80 °C in an oven 
and air dried at room temperature to yield 1.81 
g (9.1 % w/w) of crude saponin residue. Using 
foaming test (Harborne, 1973), the residue 
was screened for saponin. 
 
Chemicals, drugs and test agents 
All the solvents (methanol, n-butanol, 
diethyl ether, chloroform and acetone), 
obtained from BDH sales representative in 
Kampala (Uganda) were of the analytical 
grade. Other agents used include acetic acid 
(Sigma-Aldrich, Germany) and active dry 
Saccharomyces cerevisiae: brewer’s yeast 
(GRIFFCHEM®, Nairobi Kenya) was used to 
induce pyrexia in the antipyretic study. 300 
mg/kg acetylsalicylic acid (ASA) as reference 
standard, 5 ml/kg normal saline solution as 
placebo and crude saponin as test samples 
were used in all the experiments. Morphine 
sulphate (from project of Ministry of Health 
Molago, Kampala) as opioid reference 




120-200 g wistar rats (for antipyretic 
study) and 20 g – 25 g albino mice (for acute 
toxicity and antinociceptive study) of both 
sexes which have been acclimatized in the 
animal facility of Mbarara University of 
Science and Technology were placed in 
standard cages where they were maintain on 
standard animal pellets (obtained from Nuvita 
Feeds Ltd., Kampala) and water ad libitum. 
The rats for antipyretic study were selected 
based on their measured basal anal 
temperature (using a thermistor probe) not 
exceeding 37 0C, and achieving anal 
temperature elevation of at least 0.1 0C in 
response to intra peritoneal (i.p) 
administration of 15% w/v Saccharomyces 
cerevisiae at a dose of 10 ml/kg body weight. 
The animals for the antipyretic and 
antinociceptive studies were divided into five 
groups of five animals each and fasted 
overnight. 
The National Institute of Health (NIH) 
guide for the care and use of laboratory 
animals approved by the Institutional Ethical 
Committee was adopted for the animal 
protocol in this study (NIH, 1978). 
 
Preparation and administration of drug 
All the standards and tests samples 
were prepared using sterile normal saline 
solution which also, served as placebo in the 
different experiments. Oral (p.o) 
administration was carried out using a canula-
syringe assemblage, and hypodermic syringe-
needle assembly used for intra-peritoneal (i.p) 
administration. 
 
Acute toxicity study 
The technique as described by Miller 
and Tainter (1944) with slight modification 
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according to Ghosh (1984) adaptation was 
used. 50% lethality (LD50) of the crude 
saponin was determined in a biphasic manner. 
Animals (albino mice) were starved but 
allowed access to water for twenty four hours 
prior to the study.  In phase 1, crude saponin 
doses (500, 1000, 2000, 4000, 6000 and 8000 
mg/kg p.o), using an animal for each dose (n = 
1), were administered to establish the range of 
the expected LD50 dose. Based on data 
obtained, phase 2 investigatory step was done 
using more specific doses (4000, 4500, 5000 
and 5500 mg/kg p.o) administered to four 
other groups of five animals each (n = 5). The 
investigations were repeated using i.p 
administration of 100, 200, 300, 400, 500 and 
600 mg/kg in phase 1 (n = 1); and 200, 250, 
300 and 350 mg/kg in phase 2 (n = 5). 
In all the investigations, normal 
saline (o.p or i.p) administration to placebo 
group was used. After administration of each 
dose, the animals were observed continuously 
for two hours, occasionally for four hours 
further and finally, overnight mortality was 
recorded. LD50 was determined from the graph 
of probit (probit 5 being 50 % mortality) 
against log dose of crude saponin.  
 
Antipyretic study 
Adopting standard procedure as 
described by a previous study, wistar rats 
earlier selected and induced pyrexia were 
randomly divided into five groups of five 
animals each (Okokon and Onah, 2004). The 
animals were allowed to starve overnight in 
their respective cages. Twenty hours after the 
administration of Saccharomyces cerevisae 
solution, the anal temperature of each animal 
was measured. Oral (p.o) administration of 
normal saline to group one, ASA to group two 
and crude saponin (200, 400 and 600 mg/kg) 
to groups three to five was immediately 
carried out after the anal temperature 
measurement. Four hours after the 
administration of the dose, the anal 




Adopting literature documented 
technique, 0.6% acetic acid solution 
administered by intra peritoneal (i.p) route at a 
dose of 15 ml/kg was used to induce writhing 
(typical constriction response consisting of 
abdominal wall contraction, pelvic rotation 
and hind limb extension) 30 minutes after oral 
administration of acetylsalicylic acid (non-
opioid standard), morphine sulphate (opioid 
standard), normal saline (placebo), V. 
amygdalina aqueous extract (800 mg/kg) or 
crude saponin (600 mg/kg) to the mice 
(Collier et al., 1968). Each mouse was 
returned to the cage. Five minutes after the 
administration of acetic acid, writhing counts 
were taken for five minutes under a double 
blind observation. Antinociceptive effects 
were measured by comparing their mean 
abdominal writhes count to the mean writhe 
count of the placebo group 
((c - t or s)/c) x 100 
NB: c is mean writhes count for placebo; t or 
s is mean writhes count for any of the tests or 
standards 
Hot plate test 
Prior to dose administration, the mice 
were selected on the basis of their basal 
reaction time (fore-paw licking or jumping 
off) when placed on the hot plate which was 
maintained at 55 °C ± 1. Animals with ≤ 8 
seconds reaction time were regarded as 
appropriate for inclusion (Shanmugasundaram 
and Venkataraman, 2005). 60 minutes after 
oral administration of acetylsalicylic acid, 
morphine sulphate, normal saline, V. 
amygdalina aqueous extract (800 mg/kg) or 
crude saponin (600 mg/kg), the mice were 
similarly exposed to the hot plate. Time taken 
for either fore paw licking or jumping off the 
hot plate was documented as reaction time. 
The group reaction time was taken as mean of 
the reaction times.  15 seconds was taken as 
cut off period to avoid damage to paws. 
Maximum possible analgesia (MPA) was 
calculated according to Idid et al. (1998): ((T1-
T0) / (15- T0)) x 100. 
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NB: T1 is mean reaction time for standard or 
test; T0 is mean reaction time for placebo 
Cold tail flick test 
Procedure as described by Pizziketti et 
al. (1985) was adopted for this test. Animals 
were considered for the study based on their 
latent period of tail-flick response. Prior to 
dose administration, two cm length of the 
animal’s tail was immersed into a cold 1:1 
mixture of water and ethylene glycol 
maintained at -10 °C with an ultra low 
temperature freezer (UF 650 Napcoil, Thermo 
Electric Corporation). Animals with response 
≤ 15 seconds were selected. 60 minutes after 
oral administration of acetylsalicylic acid, 
morphine sulphate, normal saline, V. 
amygdalina aqueous extract (800 mg/kg) or 
crude saponin (600 mg/kg), animals were 
similarly exposed to the cold mixture of water 
and ethylene glycol. The response for each 
animal was taken as the elapsed time for tail 
deflection from the mixture. The first reaction 
time reading was discarded and the reaction 
time was taken as the mean of the last two 
readings. The response for each group was 
taken and documented as the mean of the 
reaction times. 30 seconds reaction cut-off 
period was used to avoid damage to the tail. 
The MPA was calculated as  
((T1-T0) / (30- T0)) x 100 
NB: T1 is mean reaction time for standard or 
test; T0 is mean reaction time for placebo 
 
Statistical analysis of data 
Results and calculations were based on 
the numerical expression of data as mean ± 
SEM. Analysis of variance (ANOVA) was 
used to analyse values within groups and 
Student t-test, to analyse data between groups. 





Standard test for phytochemical 
constituents in the aqueous extract of the dried 
powdered leaves of V. amygdalina revealed 
the presence of saponins, alkaloids, 
sophisticated lactones, triterpenoids, reducing 
sugars, amino acids, flavonoids, terpenoids, 
tannins and cardiotonic glycosides. 
 
Acute toxicity study 
LD50 for the crude saponin using the i.p 
administration was 264.48 mg/kg, while the 
p.o was 5152.3 mg/kg. Abnormal gait and 
reduction in typical activities were observed 
prior to death with higher range of the doses 
used for the different routes of administration.  
 
Antipyretic study 
The statistical analysis of the 
antipyretic study using ANOVA indicated no 
significant (P > 0.05) variance in the yeast 
induced anal temperature within and among 
groups. The t-test analysis showed a dose 
dependent anal temperature decrease with 
crude saponin (Table 1) which was significant 
(P ≤ 0.05).  
 
Antinociceptive study 
Writhing Test: The acetic acid induced 
writhe count data for the standards, aqueous 
extract and crude saponin doses were 
significantly (P ≤ 0.05) different from normal 
saline (placebo group). However, the effect of 
antinociception was markedly observed with 
morphine sulphate at 89.69% and ASA at 
86.60% (Table 2). 
Hot plate test 
Data obtained with this test showed 
significant (P ≤ 0.05) reaction time for the 
opioid standard and leaf aqueous extract 
(Table 3). 
Cold tail flick test 
Reaction time obtained with the cold 
tail flick test was significant (P ≤ 0.05) for 
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Table1: Decrease in the anal temperature of rats 4 hrs after administration of doses. 
 
Group Dose 
20 hrs after yeast administration 
the anal Temp.0C readings are 
Dose Induced 
Anal Temp.°C 
Decrease  0 hrs 
4 hrs (after 
Dose admin.) 
1. placebo 
Normal saline  5 
ml/kg 
39.054 ± 0.12 39.04 ± 0.11 0.014 ± 0.02 
2. Standard ASA 300 mg/kg 39.10 ± 0.11 *38.95 ± 0.08 0.15 ± 0.04 
3. Saponin 200 mg/kg 38.75 ± 0.25 *38. 62 ± 0.24 0.14 ± 0.02 
4. Saponin 400 mg/kg 38.78 ± 0.19 *38.49 ± 0.18 0.29 ± 0.01 
5. Saponin 600 mg/kg 38.66 ± 0.11 *38.29 ± 0.11 0.39 ± 0.01 




Table 2: Effect of V. amygdalina leaves’ aqueous extract and crude saponin in the acetic acid 







1. Placebo Normal Saline 5 ml/kg 19.4 ± 2.51 0 
2. Opioid Standard morphine sulphate 5 mg/kg *2 ± 0.71 89.69 
3. Non-opioid Standard 300 mg/kg acetylsalicylic acid *2.6 ± 0.55 86.6 
4. Aqueous Extract 800 mg/kg *5.6 ± 0.89 71.13 
5. Saponin 600 mg/kg *9.2 ± 0.84 52.58 




Table 3: Effect of V. amygdalina leaves’ aqueous extract and crude saponin in the thermal stimulus-
induced hot plate test in mice. 
 
Groups Dose 
Mean Reaction Time 
(sec) 
MPA 
1. Placebo Normal Saline 5 ml/kg 5.49  ± 0.07 0 
2. Opioid Standard morphine sulphate 5 mg/kg *9.62 ± 0.12 43.39 
3. Non-opioid Standard 300 mg/kg acetylsalicylic acid 5.51 ± 0.49 0.21 
4. Aqueous Extract 800 mg/kg *7.90 ± 0.74 25.3 
5. Saponin 600 mg/kg 5.54 ± 0.30 0.02 
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Table 4: Effect of V. amygdalina leaves’ aqueous extract and crude saponin in the thermal stimulus-
induced cold tail flick test in mice. 
 
Groups Dose Mean Reaction Time (sec) MPA 
1. Placebo Normal Saline 5 ml/kg 19.72 ± 1.11 0 
2. Opioid Standard 
morphine sulphate 5 
mg/kg 
*26.24 ± 1.29 63.42 
3. Non-opioid Standard 
300 mg/kg acetylsalicylic 
acid 
*20.56 ± 0.77 8.17 
4. Aqueous Extract 800 mg/kg *22.74 ± 0.90 29.38 
5. Saponin 600 mg/kg 19.04 ± 0.73 #-6.62 




Vernonia amygdalina leaf has been 
used over the years by natives in the Eastern 
and Western part of Africa. The use of the leaf 
as food has always required a prior processing 
leading to the loss of possible medicinal 
principles (Adetuyi et al., 2008). In the current 
study, the antipyretic and antinociceptive 
properties of a major constituent of the leaf, 
saponin, usually lost during processing for 
food due to its aqueous solubility, was 
investigated. 
In the study of the crude saponin 
activity against pyrexia, a common 
manifestation in many infectious diseases, the 
brewer’s yeast was used as an exogenous 
stimulus. This is known to induce pyrexia, 
probably in a manner similar to 
lipopolyssacharides, in laboratory animals 
(Walter, 2003). Such induction commonly 
activates the arachidonic acid pathway 
associated with increase in prostaglandin E2 
(PGE2) (Kasper et al., 2008). A study by 
David et al. (2001) was able to show that 
inhibiting the arachidonic acid pathway and 
specifically, the activity of cyclo-oxygenase, 
results in the reduction of PgE2 level within 
the hypothalamus. Such inhibitory activity 
usually decreases elevated body temperature. 
The antipyretic activity test indicated that the 
crude saponin was able to significantly (P ≤ 
0.05) decrease the yeast induced anal 
temperature elevation in the animals. This 
suggests that the crude saponin, like the 
standard, ASA possess inhibitory activity 
against the arachidonic acid pathway. Earlier 
studies shows that extract from the leaf, as 
well as the root, exhibits antipyretic activity 
(Okokon and Onah, 2004; Adiukwu et al., 
2011). However, this study indicates that 
saponin is a major participant in the observed 
antipyretic activity of the herbal extract.  
The antinociceptive study was carried 
out using the writhing, hot plate and cold tail 
flick test methods. In the writhing test, intra 
peritoneal administration of 0.6% acetic acid 
was used to induce pain in form of writhes, in 
the laboratory animals. The acid is considered 
to produce nociception by stimulating the 
release of various endogenous pain mediators 
peripherally (Raj, 1996). Such mediators 
usually excite the nociceptors and produce 
increase in the peritoneal fluid level of 
prostaglandins (PgE2 and PgF2α) and 
lipooxygenase (Du et al., 2007). Initiation of 
the resulting slow and poorly localized pain is 
via the C fibres. Writhing test data showed 
that the aqueous extract and crude saponin, 
like the opioid and non-opioid standards, were 
able to significantly (P ≤ 0.05) decrease the 
number of writhes. This observation suggests 
the possession of inhibitory property by the 
aqueous extract and crude saponin against the 
activity of the endogenous pain mediators or 
their effect. Prior study shows that writhing 
test is limited by its lack of bias for either 
central or peripheral activity (Anoka et al., 
2008). 
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In hot plate (thermal) test, pain 
stimulus is initiated through the Aδ fibres and 
inhibited centrally or interaction with the 
widely distributed opioid receptors 
peripherally (Raj, 1996). A significant (P ≤ 
0.05) increase in the mean reaction time of the 
animals, indicating pain inhibition, was 
observed for the aqueous extract. This was 
similar but less to data obtained for the opioid 
standard, morphine sulphate.  The hot plate 
technique has bias for centrally acting agents 
but not sufficiently sensitive to distinguish 
between opiates and non-opiates with central 
activity (Idid et al., 1998).  
The cold tail flick test has been 
demonstrated to sufficiently identify opiates 
from non-opiates with central activity 
(Pizziketti et al., 1985). Obtained data using 
this technique showed that the aqueous extract 
produced a significant (P ≤ 0.05) increase in 
the mean reaction time, similar to morphine 
sulphate. This was not the same for the crude 
saponin. 
Study finding supports previous data on 
the peripheral and central antinociceptive 
activity of Vernonia amygdalina leaf aqueous 
extract (Anoka et al., 2008). However, 
obtained data suggests that saponin may be 
responsible or contributory to the non-opioid-
like peripherial antinociceptive property of the 
leaf aqueous extract. An earlier analgesic and 
anti-inflammatory in vivo study with Vernonia 
cinerea suggests the presence of 
phytochemicals like saponins to be 
responsible for observed antinociceptive 
property (Iwalewa and Adeboye, 2003). 
Saponins are generally considered to be 
toxic with majority regarded to be powerful 
haemolytics in vitro. However, large doses 
may be needed to produce toxic effect when 
administered parenterally, and larger doses 
due to poor absorption when administered 
orally. Several toxicity tests have shown that 
the lethal oral dose of saponins is 3–1000 
times as large as the lethal intravenous dose 
(George, 1965). As such, toxicity of saponins 
to warm blooded animals is dependent on the 
method of administration, source, 
composition, and concentration of the saponin 
mixture (Liu and Henkel, 2002). In this study, 
the LD50 data obtained for i.p administered 
crude saponin indicates approximately, twenty 
times more toxicity than the p.o administered 
dose.   
In common terms, a LD50 dose of 2000 
mg/kg and above is categorized as 
unclassified and hence safe (OECD, 1987). 
Data obtained in previous studies (Anoka et 
al., 2008; Ojiako and Nwanjo, 2006) showed 
that the i.p administered aqueous extract of 
the leaf is moderately to slightly toxic (Ghosh, 
1984). Study by Anoka et al., (2008) showed 
that the orally administered extract was 
slightly toxic in rats. Data in this study 
indicated that the crude saponin from the 
extract is practically non-toxic orally and 
moderately toxic intra-peritoneally. 
Previous in vivo studies using rats, 
mice and rabbits showed that saponins are not 
absorbed in the alimentary channel but 
hydrolyzed to their corresponding sapogenins 
(aglycone) and sugar(s) by enzymatic action 
in the gastrointestinal tract (Güçlü-Ustündağ 
and Mazza, 2007; Gestetner et al., 1968). The 
readily more absorbable aglycone is because 
of this reason, usually considered to be 
responsible for most of the associated 
activities with the orally administered 
saponins. This may explain the safety of the 
orally administered saponin rich Vernonia 
amygdalina leaf aqueous extract in herbal 
therapy, or the consumption of the leaf as diet 
(Adiukwu et al., 2011).  
 
Conclusion 
 The crude saponin from Vernonia 
amygdalina leaf aqueous extract, administered 
orally, has been shown by this study to 
possess substantial antipyretic and 
antinociceptive activity. However, the saponin 
constituent is known as one of the principles 
lost during processing of the leaf for food. In 
this regard, ailing persons with pyrexia and 
pains may benefit from the leaf of Vernonia 
amygdalina diet if processing technique is 
adapted to reduce loss of essential nutritional 
and medicinal constituents like saponin. 
Whereas data obtained in the current study 
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may support the folkloric use of the herb by 
ethnics, the crude saponin is worth probing 
further for development into a phyto-drug 
with the hope that it will produce beneficial 
effect, similar to the herbal experience. 
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